The QSP model describes the pharmacokinetics of anti-PD-(L)1, interactions between the antibodies and their molecular targets, tumor cell dynamics, intra-tumoral T cell dynamics, and CTL-mediated tumor cell killing (Figure 1A). The gene discussed is CD274; the disease is neoplasm.